Skip to main navigation Skip to search Skip to main content

Cediranib and Olaparib Combination Compared with Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005

  • Jung Min Lee
  • , Mark F. Brady
  • , Austin Miller
  • , Richard G. Moore
  • , Helen MacKay
  • , Leah McNally
  • , Jayanthi Lea
  • , Daron Street
  • , Stephanie Lheureux
  • , Megan E. McDonald
  • , Linda R. Duska
  • , Guilherme Cantuaria
  • , Juraj Kavecansky
  • , Charles A. Leath
  • , Matthew Powell
  • , Mark G. Cadungog
  • , Peter G. Rose
  • , Yong Man Kim
  • , Helen Q. Huang
  • , Michèle Provencher
    • Lari B. Wenzel, Michael A. Bookman, Elise C. Kohn, Angeles Alvarez Secord

Research output: Contribution to journal › Article › peer-review

19   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Cediranib and Olaparib Combination Compared with Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science